rs63751294
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_002087.4(GRN):c.1477C>T(p.Arg493Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000144 in 1,461,638 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.000014 ( 0 hom. )
Consequence
GRN
NM_002087.4 stop_gained
NM_002087.4 stop_gained
Scores
2
2
3
Clinical Significance
Conservation
PhyloP100: 0.481
Genes affected
GRN (HGNC:4601): (granulin precursor) Granulins are a family of secreted, glycosylated peptides that are cleaved from a single precursor protein with 7.5 repeats of a highly conserved 12-cysteine granulin/epithelin motif. The 88 kDa precursor protein, progranulin, is also called proepithelin and PC cell-derived growth factor. Cleavage of the signal peptide produces mature granulin which can be further cleaved into a variety of active, 6 kDa peptides. These smaller cleavage products are named granulin A, granulin B, granulin C, etc. Epithelins 1 and 2 are synonymous with granulins A and B, respectively. Both the peptides and intact granulin protein regulate cell growth. However, different members of the granulin protein family may act as inhibitors, stimulators, or have dual actions on cell growth. Granulin family members are important in normal development, wound healing, and tumorigenesis. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 17-44352404-C-T is Pathogenic according to our data. Variant chr17-44352404-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 16014.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-44352404-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRN | NM_002087.4 | c.1477C>T | p.Arg493Ter | stop_gained | 12/13 | ENST00000053867.8 | NP_002078.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRN | ENST00000053867.8 | c.1477C>T | p.Arg493Ter | stop_gained | 12/13 | 1 | NM_002087.4 | ENSP00000053867 | P1 | |
GRN | ENST00000589265.5 | c.1006C>T | p.Arg336Ter | stop_gained | 8/9 | 5 | ENSP00000467616 | |||
GRN | ENST00000586443.1 | c.919C>T | p.Arg307Ter | stop_gained | 7/7 | 3 | ENSP00000465673 | |||
GRN | ENST00000586242.1 | c.112C>T | p.Arg38Ter | stop_gained | 2/3 | 3 | ENSP00000467837 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251110Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135818
GnomAD3 exomes
AF:
AC:
2
AN:
251110
Hom.:
AF XY:
AC XY:
0
AN XY:
135818
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461638Hom.: 0 Cov.: 34 AF XY: 0.0000165 AC XY: 12AN XY: 727158
GnomAD4 exome
AF:
AC:
21
AN:
1461638
Hom.:
Cov.:
34
AF XY:
AC XY:
12
AN XY:
727158
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:7Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:3Other:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 22, 2020 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; One of the most common variants reported in the GRN gene in individuals with frontotemporal dementia (Gass et al., 2006; Huey et al., 2006; Rademakers et al., 2007); Published functional studies demonstrate a damaging effect (Fujita et al., 2018); This variant is associated with the following publications: (PMID: 16983677, 28473694, 21482928, 24703252, 22608501, 26791154, 27341800, 28304311, 29080331, 16950801, 17826340, 17522386, 28404863, 22312439, 18703462, 17210807, 17071927, 17345602, 29382817, 30279455, 31031559, 29511098, 29724592, 29146050, 30696728, 31361008, 31996268, 30924900, 33351065) - |
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 20, 2017 | - - |
not provided, no classification provided | literature only | VIB Department of Molecular Genetics, University of Antwerp | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | AiLife Diagnostics, AiLife Diagnostics | Mar 21, 2022 | - - |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions Pathogenic:2Other:1
Pathogenic, criteria provided, single submitter | clinical testing | North West Genomic Laboratory Hub, Manchester University NHS Foundation Trust | Aug 31, 2021 | Criteria Codes: PVS1 PS3 PS4_Mod PM2_Supp PP1 - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 2011 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
GRN-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 30, 2024 | The GRN c.1477C>T variant is predicted to result in premature protein termination (p.Arg493*). This variant has been reported to be pathogenic for frontotemporal lobar degeneration (Gass et al. 2006. PubMed ID: 16950801; Rademakers et al. 2007. PubMed ID: 17826340; Huey et al. 2006. PubMed ID: 16983677). This variant is reported in 0.0062% of alleles in individuals of African descent in gnomAD. Nonsense variants in GRN are expected to be pathogenic and this variant has been consistently classified as pathogenic in ClinVar. This variant is interpreted as pathogenic. - |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions;C3539123:Neuronal ceroid lipofuscinosis 11 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 02, 2023 | This sequence change creates a premature translational stop signal (p.Arg493*) in the GRN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GRN are known to be pathogenic (PMID: 16862116, 16950801, 22608501). This variant is present in population databases (rs63751294, gnomAD 0.005%). This premature translational stop signal has been observed in individuals with frontotemporal dementia and primary progressive aphasia (PMID: 16950801, 26791154, 30279455). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 16014). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Benign
N
MutationTaster
Benign
A;A
Vest4
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at